Publication | Closed Access

Efficacy and toxicity of 2-chlorodeoxyadenosine (cladribine)—2h infusion for 5 days—as first-line treatment for advanced low grade non-Hodgkin’s lymphoma

Lymphoid NeoplasiaOncologyMedicineMalignant Blood DisorderHematologyDays—as First-line TreatmentPharmacotherapyPharmacology